While social media staples such as Twitter, Facebook, LinkedIn, and others have become standard marketing procedure for most pharmaceutical companies, a new trend has emerged – using custom social media-like platforms to solve the critical, more specific communications challenges that are commonplace throughout the drug lifecycle. Called “online discussion platforms”, these solutions take the best features of social media communication, augment them with heavy compliance safeguards, and tailor them for specific use by life sciences professionals and their extended healthcare stakeholders.
The article discusses several ways that these platforms are being used to engage large groups.
This experience exceeded my expectations. I think this is a useful technology and way to gain KOL insight, particularly with large groups located around the country – and globe.National Medical Affairs Director